Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency syndrome (AIDS). AIDS is characterized by CD4+ T lymphocyte depletion. Tat, the viral trans-activator encoded by the HIV-1 genome, is responsible for HIV-1 replication at the transcriptional level in HIV-1 infected cells by binding the trans-activation response region (TAR) and recruiting cdk9/cyclin T1, p300/CBP, SWI/SNF, and RNA Polymerase II. Sustained HIV-1 replication further progresses infected T cells towards AIDS. The long-term goal of our research is to understand how the chromatin environment, Tat, and chromatin remodelers/modifiers cooperate to influence HIV-1 transcription. Tat, in its unmodified form, associates with the histone acetyltransfersase p300/CBP. However, we have recently found that acetylated Tat binds BRG1, a component of the SWI/SNF chromatin remodeling complex. A further test of which SWI/SNF complex is involved in activated transcription points to specific use of PBAF complex. This Tat-SWI/SNF complex is sufficient to remove/remodel nuc-1 from the HIV-1 promoter to allow for TAR-specific HIV-1 transcription. We also show that BRG1 and Baf200 play critical role in HIV-1 replication. Therefore, these results led us to speculate that Tat-SWI/SNF plays a role Tat activated HIV-1 transcription. Our hypothesis is that unmodified Tat complexes with p300/CBP and cdk9/cyclin T1 to initiate HIV-1 transcription while acetylated Tat complexes with SWI/SNF and p300/CBP- associated factor (p/CAF) to promote transcriptional elongation. However, p300/CBP may also be involved in Tat-mediated transcriptional elongation. Our rationale for these studies is based on mounting data demonstrating that the chromatin environment and chromatin-associated factors are critical in regulating HIV-1 expression. Hence, there is now added emphasis on identifying chromatin factors/modifications that aid in transition through the inhibitory chromatin complex. . The following specific aims address our hypothesis: (I) What is the significance of the Tat-p300/CBP and Tat-p/CAF complexes in chromatin marking and transcription elongation on the HIV-1 promoter and open reading frames in cell lines and PBMC infected cells? (II) What is the role of the Tat- SWI/SNF (Tat-PBAF) complex in chromatin remodeling at the HIV-1 LTR in infected cell lines and PBMC infected cells? Data obtained from these studies will shed light on how the chromatin environment regulates Tat activated HIV-1 transcription.

Public Health Relevance

Narrative Human immunodeficiency virus (HIV) is the causative agent of acquired immunodeficiency syndrome (AIDS). A viral protein encoded by the HIV-1 genome (Tat), is responsible for HIV-1 replication at the level of DNA. Our research seeks to understand how the proteins and factors (chromatin) present on HIV-1 DNA influence viral expression when acting through the actions of Tat. Based on the mounting data demonstrating that the chromatin environment is critical in regulating HIV-1 expression, there is now an added emphasis on chromatin-associated proteins as novel therapeutic targets. This work will shed new light on the role of chromatin in Tat-mediated HIV-1 expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
7R21AI074410-02
Application #
8082018
Study Section
AIDS Molecular and Cellular Biology Study Section (AMCB)
Program Officer
Salzwedel, Karl D
Project Start
2009-07-22
Project End
2013-06-30
Budget Start
2010-07-01
Budget End
2013-06-30
Support Year
2
Fiscal Year
2010
Total Cost
$181,875
Indirect Cost
Name
George Mason University
Department
Type
Schools of Arts and Sciences
DUNS #
077817450
City
Fairfax
State
VA
Country
United States
Zip Code
22030
Meltzer, Beatrix; Dabbagh, Deemah; Guo, Jia et al. (2018) Tat controls transcriptional persistence of unintegrated HIV genome in primary human macrophages. Virology 518:241-252
Anderson, Monique R; Pleet, Michelle L; Enose-Akahata, Yoshimi et al. (2018) Viral antigens detectable in CSF exosomes from patients with retrovirus associated neurologic disease: functional role of exosomes. Clin Transl Med 7:24
DeMarino, Catherine; Pleet, Michelle L; Cowen, Maria et al. (2018) Antiretroviral Drugs Alter the Content of Extracellular Vesicles from HIV-1-Infected Cells. Sci Rep 8:7653
Zapata, Juan C; Campilongo, Federica; Barclay, Robert A et al. (2017) The Human Immunodeficiency Virus 1 ASP RNA promotes viral latency by recruiting the Polycomb Repressor Complex 2 and promoting nucleosome assembly. Virology 506:34-44
Hu, Guoku; Yelamanchili, Sowmya; Kashanchi, Fatah et al. (2017) Proceedings of the 2017 ISEV symposium on ""HIV, NeuroHIV, drug abuse, & EVs"". J Neurovirol 23:935-940
Ojha, Chet Raj; Lapierre, Jessica; Rodriguez, Myosotys et al. (2017) Interplay between Autophagy, Exosomes and HIV-1 Associated Neurological Disorders: New Insights for Diagnosis and Therapeutic Applications. Viruses 9:
Barclay, Robert A; Schwab, Angela; DeMarino, Catherine et al. (2017) Exosomes from uninfected cells activate transcription of latent HIV-1. J Biol Chem 292:11682-11701
Sampey, Gavin C; Saifuddin, Mohammed; Schwab, Angela et al. (2016) Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA. J Biol Chem 291:1251-66
Ahsan, Noor A; Sampey, Gavin C; Lepene, Ben et al. (2016) Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection. Front Microbiol 7:139
Pleet, Michelle L; Mathiesen, Allison; DeMarino, Catherine et al. (2016) Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction. Front Microbiol 7:1765

Showing the most recent 10 out of 30 publications